Comparative Analysis of the Combined Therapeutic Effects of Lipoprostaglandin E1 on Sudden Idiopathic Sensorineural Hearing Loss

다국어 초록 (Multilingual Abstract)

Background and Objectives: Viral and vascular disorders are considered to be a major cause of idiopathic sudden sensorineural hearing loss (ISSNHL). Lipoprostaglandin E1 (lipo- PGE1) has vasodilating activity and has been used to treat ISSNHL. The purpose of this study was to determine the specific therapeutic effects of lipo-PGE1 and compare them to other treatment modalities for ISSNHL. Subjects and Methods: The study group had 1,052 patients diagnosed with ISSNHL. All were treated with steroid, carbogen inhalation, stellate ganglion block (SGB), or PGE1. The CP group (steroid, carbogen inhalation, and PGE1 injection; 288 patients) was treated with lipo-PGE1 and carbogen inhalation, the CS group (steroid, carbogen inhalation, and stellate ganglion block; 232 patients) with steroid, carbogen inhalation, and SGB, the C group (steroid and carbogen inhalation; 284 patients) with steroid and carbogen, and the control group (steroid only; 248 patients) with steroid only. Patients in the groups receiving lipo-PGE1 received a continuous infusion of 10 μL lipo-PGE1. Results: The overall recovery rate after treatment was 52.2%, and recovery rates by group were 67.7% in the CP group, 54.3% in the CS group, 52.1% in the C group, and 32.2% in the control group. Therefore, the therapeutic results in groups treated with lipo-PGE1 were better than results in other groups. The difference was statistically significant. Conclusions: The study results suggested that the CP group received effective treatment modalities for ISSNHL. The combined therapy of lipo-PGE1 with carbogen inhalation in patients with ISSNHL was more beneficial than other treatment modalities.

참고문헌 (Reference)

1 Wilson WR, "Viral and epidemiologic studies of idiopathic sudden hearing loss" 91 : 653-658, 1983

2 Clifford PC, "Treatment of vasospastic disease with prostaglandin E1. Treatment of vasospastic disease with prostaglandin E1" 281 : 1031-1034, 1980

3 Gianoli GJ, "Transtympanic steroids for treatment of sudden hearing loss" 125 : 142-146, 2001

4 Ahn JH, "Therapeutic effect of lipoprostaglandin E1 on sudden hearing loss" 26 : 245-248, 2005

5 Alexiou C, "Sudden sensorineural hearing loss: does application of glucocorticoids make sense?" 127 : 253-258, 2001

6 Hughes GB, "Sudden sensorineural hearing loss" 29 : 393-405, 1996

7 Kallinen J, "Sudden deafness:a comparison of anticoagulant therapy and carbogen inhalation therapy" 106 : 22-26, 1997

8 Haug O, "Stellate ganglion blocks for idiopathic sensorineural hearing loss" 102 : 5-8, 1976

9 Chang J, "Short-term outcomes of acute low-tone sensorineural hearing loss according to treatment modality" 20 : 47-52, 2016

10 Fetterman BL, "Prognosis and treatment of sudden sensorineural hearing loss" 17 : 529-536, 1996

11 Mattox DE, "Natural history of sudden sensorineural hearing loss" 86 (86): 463-480, 1977

12 Fisch U, "Measurement of oxygen tension in human perilymph" 81 : 278-282, 1976

13 Haberkamp TJ, "Management of idiopathic sudden sensorineural hearing loss" 20 : 587-592, 1999

14 노경진, "Long-Term Outcomes of Acute Low-Tone Hearing Loss" 대한청각학회 19 (19): 74-78, 2015

15 Doyle KJ, "Intratympanic steroid treatment: a review" 25 : 1034-1039, 2004

16 Choung YH, "Intratympanic dexamethasone injection for refractory sudden sensorineural hearing loss" 116 : 747-752, 2006

17 Chandrasekhar SS, "Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation" 22 : 18-23, 2001

18 Khetarpal U, "Idiopathic sudden sensorineural hearing loss and postnatal viral labyrinthitis: a statistical comparison of temporal bone findings" 99 : 969-976, 1990

19 Mattox DE, "Idiopathic sudden sensorineural hearing loss" 10 : 242-247, 1989

20 Goycoolea MV, "Experimental studies on round window structure: function and permeability" 98 (98): 1-20, 1988

21 Nakashima T, "Evaluation of prostaglandin E1therapy for sudden deafness" 99 : 542-546, 1989

22 Nishimura T, "Effects of intravenous administration of prostaglandin E(1) and lipo-prostaglandin E(1) on cochlear blood flow in guinea pigs" 259 : 253-256, 2002

23 Ogawa K, "Effect of prostaglandin E1on idiopathic sudden sensorineural hearing loss: a double-blinded clinical study" 23 : 665-668, 2002

24 Kallinen J, "Effect of carbogen inhalation on peripheral tissue perfusion and oxygenation in patients suffering from sudden hearing loss" 108 : 944-947, 1999

25 Murray KJ, "Cyclic AMP and mechanisms of vasodilation" 47 : 329-345, 1990

26 Parnes LS, "Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application" 109 (109): 1-17, 1999

27 이재우, "Clinical Features and Prognosis of Sudden Sensorineural Hearing Loss Secondary to Intralabyrinthine Hemorrhage" 대한청각학회 20 (20): 31-35, 2016

28 Salganicoff L, "An hypothesis on the consolidation and PGE1-induced deconsolidation of a platelet plug" 14 : 463-471, 2003